Ameriprise Financial »

Eupraxia Pharmaceuticals shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 524k 7.24

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Lam Research (LRCX)
iShares S&P 500 Index (IVV)
Chevron Corporation (CVX)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Johnson & Johnson (JNJ)
Visa (V)

View all positions for Ameriprise Financial

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Ameriprise Financial
Woodline Partners
Seven Fleet Capital Management

View all funds holding Eupraxia Pharmaceuticals